Avanish Vellanki - 11 Mar 2022 Form 4 Insider Report for Rain Therapeutics Inc.

Role: President and CEO, Director
Signature: /s/ Nelson Cabatuan, Attorney-in-fact for Avanish Vellanki
Issuer symbol: N/A
Transactions as of: 11 Mar 2022
Net transactions value: +$57,872
Form type: 4
Filing time: 15 Mar 2022, 15:23:10 UTC
Previous filing: 04 Feb 2022
Next filing: 15 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RAIN	Common Stock	Options Exercise	$57,872	+14,468	+0.51%	$4.00	2,837,009	11 Mar 2022	Direct
holding	RAIN	Common Stock						138,901	11 Mar 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAIN	Stock Option (Right to Buy)	Options Exercise	$0	-14,468	-31%	$0.000000	31,832	11 Mar 2022	Common Stock	14,468	$4.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option represents a right to purchase a total of 46,300 shares of the Issuer's common stock, which vests in equal monthly installments through November 13, 2024, subject to the Reporting Person's continued service to the Issuer.